Home Gut gateway to generalized pain
Article Publicly Available

Gut gateway to generalized pain

  • Arnold Berstad EMAIL logo and Jørgen Valeur
Published/Copyright: October 1, 2016
Become an author with De Gruyter Brill

In this issue of Scandinavian Journal of Pain, Marum and coworkers [1] report that a diet low in FODMAPs, “fermentable oligo-, di- and monosaccharides, and polyols”, is effective in treating complaints related to fibromyalgia, a rheumatic disease characterized by widespread myofascial pain of unknown aetiology.

1 Fermentable oligo-, di- and monosaccharides, and polyols = FODMAPs may aggravate fibromyalgia symptoms

The authors performed an open pilot study on the effect of a low-FODMAP diet in 38 patients with fibromyalgia. The main comorbidity of the cohort was irritable bowel syndrome (IBS) and some form of food intolerance. The low-FODMAP diet has emerged as an established therapy in IBS [2]. Consistent with prior studies, scores on IBS symptom severity decreased by 50% after one month on the diet [1]. The new findings are that the impact of fibromyalgia scores also decreased (by 22%) and scores of improvements for fibromyalgia and IBS were significantly correlated to each other and to compliance with the diet [1].

2 Low-FODMAP diet improves fibromyalgia symptoms – also in controlled studies?

Marum and co workers [1] highlight the importance of the relationship between fibromyalgia and gastrointestinal disturbances and suggest that diet might constitute an important part of the therapy. Patients with such “medically unexplained physical symptoms” are often frustrated due to lack of effective treatment. We suspect that such frustration may complicate an open trial evaluation of a dietary intervention. Experiencing relief of abdominal discomfort, the patients may become over-enthusiastic and liable to score the total benefit, including relief of musculoskeletal pain, a little too generously. Further controlled studies are therefore required.

3 Fibromyalgia syndrome and irritable bowel syndrome

Fibromyalgia is characterized by chronic generalized pain accompanied by a broad spectrum of symptoms from various organs, including food intolerances and IBS, that are commonly overlooked [3]. The central sensitivity syndrome is a novel concept embracing the biopsychosocial model of the condition [4]. However, this concept implies nothing about where and how the abnormality begins. According to our personal experience, the patients regularly report abdominal complaints, often years before the appearance of musculoskeletal pain [5]. Also, a majority of the patients feel that diet helps, at least for their food intolerances. Nevertheless, current therapy is still largely based on a psychological approach.

4 Disturbed gut microbiota associated with the triad: fibromyalgia–IBS–chronic fatigue

The present study is important because it may be the first to suggest that a diet low in FODMAPs may be beneficial in fibromyalgia. The suggestion is timely: diet has a considerable influence on the gut microbiota [6], and disturbances of the gut microbiota (“dysbioses”) are associated with a number of diseases, including “medically unexplained physical symptoms”, such as IBS, fibromyalgia and chronic fatigue syndrome [7]. Studies in animal models clearly document that gut microbiota alters brain functions (“microbiota–gut–brain axis”) [8] suggesting that the gut may be a gateway to generalized pain, including the pain experienced by patients with fibromyalgia.


DOI of refers to article: http://dx.doi.org/10.1016/j.sjpain.2016.07.004.


  1. Conflict of interest: None declared.

References

[1] Marum AP, Moreira C, Saraiva F, Tomas-Carus P, Guerreiro CS. Low FODMAP diet reduce pain and improve impact on daily life of fibromyalgia patients. Scand J Pain 2016;13:166–72.Search in Google Scholar

[2] Marsh A, Eslick EM, Eslick GD. Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis. Eur J Nutr 2016;55:897–906.Search in Google Scholar

[3] Yunus MB. Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes. Semin Arthritis Rheum 2007;36: 339–56.Search in Google Scholar

[4] Slim M, Calandre EP, Rico-Villademoros F. An insight into the gastrointestinal component of fibromyalgia: clinical manifestations and potential underlying mechanisms. Rheumatol Int 2015;35:433–44.Search in Google Scholar

[5] Berstad A, Undseth R, Lind R, Valeur J. Functional bowel symptoms, fibromyalgia and fatigue: a food-related triad? Scand J Gastroenterol 2012;47:914–9.Search in Google Scholar

[6] Maukonen J, Saarela M. Human gut microbiota: does diet matter? Proc Nutr Soc 2015;74:23–36.Search in Google Scholar

[7] Collins SM, Bercik P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology 2009;136:2003–14.Search in Google Scholar

[8] Mu C, Yang Y, Zhu W. Gut microbiota: the brain peacekeeper. Front Microbiol 2016;7:345.Search in Google Scholar

Published Online: 2016-10-01
Published in Print: 2016-10-01

© 2016 Scandinavian Association for the Study of Pain

Articles in the same Issue

  1. Scandinavian Journal of Pain
  2. Editorial comment
  3. Increased deep pain sensitivity in persistent musculoskeletal pain but not in other musculoskeletal pain states
  4. Clinical pain research
  5. Increased deep pain sensitivity in persistent musculoskeletal pain but not in other musculoskeletal pain states
  6. Editorial comment
  7. Patient Reported Outcomes (PROs) are sensitive outcome-variables in patients with chronic pain: Importance of self-efficacy
  8. Observational study
  9. Using patient reported outcomes in oncology clinical practice
  10. Editorial comment
  11. Cortical reorganization of the healthy hand in upper-limb complex regional pain syndrome(CRPS): Is reorganizations of common beliefs about CRPS necessary?
  12. Original experimental
  13. An exploration into the cortical reorganisation of the healthy hand inupper-limb complex regional pain syndrome
  14. Editorial comment
  15. Is there hope for the most complicated chronic pain patients facing back surgery?
  16. Educational case report
  17. A preoperative interdisciplinary biopsychosocial opioid reduction program in patients on chronic opioid analgesia prior to spine surgery: A preliminary report and case series
  18. Editorial comment
  19. Pain management in the Emergency Department – Still a long way to go?
  20. Clinical pain research
  21. Mandatory documentation of pain in the emergency department increases analgesic administration but does not improve patients’ satisfaction of pain management
  22. Editorial comment
  23. Pain relief during childbirth: Efficacy and safety of prolonging labour-analgesia with morphine directly into the lumbar cerebro-spinal-fluid (CSF)
  24. Systematic review
  25. Prolonging the duration of single-shot intrathecal labour analgesia with morphine: A systematic review
  26. Editorial comment
  27. The intricate relationship amongst pain intensity, fear and avoidance
  28. Systematic review
  29. A meta-analysis of fear-avoidance and pain intensity: The paradox of chronic pain
  30. Editorial comment
  31. Local infiltration analgesia(LIA), risk of local anaesthetic systemic toxicity (LAST) and kidney failure from NSAID in elderly patients
  32. Topical review
  33. Local infiltration analgesia in knee and hip arthroplasty efficacy and safety
  34. Editorial comment
  35. Analysis of pain-intensity measurements
  36. Topical review
  37. How to analyze the Visual Analogue Scale: Myths, truths and clinical relevance
  38. Editorial comment
  39. The relationship between chronic pain and cardiovascular disease: Squaring the circle?
  40. Systematic review
  41. Assessing the relationship between chronic pain and cardiovasculardisease: A systematic review and meta-analysis
  42. Editorial comment
  43. Optimists fare better when chronic pain strikes – Or does pain related disability make us pessimists?
  44. Observational study
  45. Constructs of health belief and disabling distal upper limb pain
  46. Editorial comment
  47. Attitude and belief of pain-therapists are important when trying to help chronic pain patients: The Norwegian version of the Pain Attitudes and Beliefs Scale (PABS) improved by Rasch analysis
  48. Observational study
  49. Rasch analysis resulted in an improved Norwegian version of the Pain Attitudes and Beliefs Scale(PABS)
  50. Editorial comment
  51. Anxiety could play a larger role than depression in migraine headache
  52. Clinical pain research
  53. The relative importance of anxiety and depression in pain impact in individuals with migraine headaches
  54. Editorial comment
  55. Bringing the lab to the people: Experimental pain testing in the general population
  56. Clinical pain research
  57. Pressure and cold pain threshold reference values in a large, young adult, pain-free population
  58. Editorial comment
  59. Improving pain treatment in children
  60. Clinical pain research
  61. A randomized controlled trial of amitriptyline versus gabapentin for complex regional pain syndrome type I and neuropathic pain in children
  62. Editorial comment
  63. Gut gateway to generalized pain
  64. Original experimental
  65. A low fermentable oligo-di-mono saccharides and polyols(FODMAP) diet reduced pain and improve ddaily life in fibromyalgia patients
  66. Editorial comment
  67. Measuring outcomes of pain management
  68. Clinical pain research
  69. Osteoarthritis patients with pain improvement are highly likely to also have improved quality of life and functioning. A post hoc analysis of a clinical trial
  70. Clinical pain research
  71. Construct validity and reliability of Finnish version of Örebro Musculoskeletal Pain Screening Questionnaire
  72. Observational study
  73. Total sleep deprivation and pain perception during cold noxious stimuli in humans
  74. Corrigendum
  75. Corrigendum to ‘Reliability of pressure pain threshold testing in healthy pain free young adults’ [Scand. J. Pain 9 (2015) 38–41]
Downloaded on 23.10.2025 from https://www.degruyterbrill.com/document/doi/10.1016/j.sjpain.2016.06.001/html?lang=en
Scroll to top button